Medicare Advantage enrollment is projected to represent the majority of Medicare beneficiaries enrolled in both Part A and Part B by 2023. This event will discuss this trend and the financial implications.
Analysis of cases that went through dispute resolution found the final allowed were largely anchored to the established.
This two-day program aims to provide social science researchers with biomedical and clinical foundations of ADRD.
White papers, journal articles, perspectives and more on the pharmaceutical supply chain from USC Schaeffer Center researchers.
USC has received $5.8 million from Gates Ventures and the American Heart Association to launch a lab aimed at diversifying clinical trials.